You obviously didn't understand what I said in my post.
I said C1 costs could go down as the project is ramped up to 1 million tonnes.
QUOTE
"When E25 ramps up to 1 million tonnes annually this could lower C1 costs, however its not till H2 2022, ( according to the announcement)"
The transport contract will have a clause to increase if the oil/diesel price goes up.
Whilst E25 has only produced 74,000 tonnes over the past 5 months, (15,000t/m) and does plan to increase this to 30,000t/m for stage 1, it could reduce C1 costs marginally, but it will only be in the order of $5/t as the material still has to be dug out, still has to be transported to the treatment site to be beneficiated and then transported to port. You need two trucks for every one used previously so costs don't come down much.
Even at full nameplate Stage 1, I see an overall loss of A$60/tonne.
Lets see what it is in 6 months time.
- Forums
- ASX - By Stock
- E25
- Ann: Revised Shipping Strategy Yields Substantial Cost Reduction
E25
element 25 limited
Add to My Watchlist
0.00%
!
22.5¢

Ann: Revised Shipping Strategy Yields Substantial Cost Reduction, page-20
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.43M |
Open | High | Low | Value | Volume |
22.5¢ | 22.5¢ | 21.5¢ | $21.94K | 100.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2779 | 21.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 62609 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2779 | 0.215 |
2 | 5119 | 0.210 |
2 | 8107 | 0.205 |
7 | 59405 | 0.200 |
3 | 13077 | 0.195 |
Price($) | Vol. | No. |
---|---|---|
0.225 | 62609 | 2 |
0.230 | 72958 | 1 |
0.235 | 24800 | 2 |
0.240 | 252084 | 2 |
0.245 | 21276 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
E25 (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online